Suboptimal teen self-care is associated with poor transition outcomes in T1D. Innovative curricula may optimize self-care engagement and transition preparation. We evaluated a pilot RCT to improve self-care and transition readiness in teens with uncontrolled T1D. Teens (N=40) were randomized to Self-Management, Adherence and Readiness for Transition in T1D (SMART T1D) curriculum or control group. The SMART T1D group participated in 3 evening peer group sessions facilitated by RN/CDEs over ∼9 months. Controls received 3 educational newsletters. All maintained routine 1:1 T1D care. Outcomes included diabetes self-care (SCI-R), transition readiness (RISQ), burden (PAID), self-efficacy (DMSE), and quality of life (Peds-QL Diabetes) and HbA1c, all assessed as change from baseline in intent-to-treat analyses with paired 1-sided t-tests. Teens were 50% male, 85% white, age 15.7±1.2 years, T1D duration 6.4±3.9 years, A1c 9.5±1.2%; 63% pump users. 38/40 completed the study. The SMART T1D group demonstrated significantly improved diabetes self-efficacy and transition readiness and a trend of improved HbA1c while control group did not (Table 1). Other domains showed no change, with a trend for increased burden in controls. SMART T1D feedback was highly positive. Peer group education may be promising for enhancing teen self-care and transition preparation.


K. Garvey: None. T. Dean: None. S. Christensen: None. K. Rice: None. V.B. Rich: None. S. Terrio: None. L. Berbert: None. E. Liu: None. L.M. Laffel: Advisory Panel; Self; Roche Diabetes Care. Consultant; Self; Boehringer Ingelheim Pharmaceuticals, Inc., ConvaTec Inc., Dexcom, Inc., Insulet Corporation, Insulogic LLC, Janssen Pharmaceuticals, Inc., Lilly Diabetes, Novo Nordisk Inc., Sanofi US.


National Institute of Diabetes and Digestive and Kidney Diseases (1K23DK202655)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at